Clinical development time is shorter for new anticancer drugs approved via accelerated approval in the US or via conditional approval in the EU

Abstract The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) offer expedited regulatory approval programs for drugs with high potential patient value applicable at different stages leading to marketing authorization: (i) drug development (fast track designation (FTD), b...

Full description

Saved in:
Bibliographic Details
Main Authors: Ebru Demirci (Author), Grace Omes‐Smit (Author), Alex Zwiers (Author)
Format: Book
Published: Wiley, 2023-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available